Federated Hermes’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.92M Buy
306,464
+13,614
+5% +$106K ﹤0.01% 889
2025
Q4
$2.28M Buy
292,850
+27,345
+10% +$198K ﹤0.01% 935
2025
Q3
$2.02M Sell
265,505
-32,696
-11% -$272K ﹤0.01% 929
2025
Q2
$2.67M Buy
298,201
+113,297
+61% +$1.06M 0.01% 868
2025
Q1
$1.39M Buy
184,904
+16,947
+10% +$137K ﹤0.01% 1026
2024
Q4
$1.26M Buy
167,957
+56,930
+51% +$432K ﹤0.01% 1044
2024
Q3
$844K Buy
+111,027
New +$844K ﹤0.01% 1180
2022
Q2
Sell
-348
Closed -$6K 2149
2022
Q1
$6K Sell
348
-47,893
-99% -$768K ﹤0.01% 1933
2021
Q4
$668K Sell
48,241
-819,896
-94% -$10.9M ﹤0.01% 1402
2021
Q3
$12.5M Buy
868,137
+121,166
+16% +$1.91M 0.02% 592
2021
Q2
$11.8M Buy
746,971
+722,057
+2,898% +$9.81M 0.02% 603
2021
Q1
$253K Buy
24,914
+24,750
+15,091% +$255K ﹤0.01% 1670
2020
Q4
$1K Buy
+164
New +$845 ﹤0.01% 2157
2019
Q4
Sell
-331,172
Closed -$949K 2212
2019
Q3
$949K Sell
331,172
-277,144
-46% -$862K ﹤0.01% 1289
2019
Q2
$2.31M Sell
608,316
-171,090
-22% -$1.03M 0.01% 1018
2019
Q1
$6.34M Buy
779,406
+343,269
+79% +$2.94M 0.02% 712
2018
Q4
$3.52M Buy
436,137
+434,756
+31,481% +$3.38M 0.01% 841
2018
Q3
$11K Buy
+1,381
New +$9.28K ﹤0.01% 1938
2017
Q3
Sell
-69,320
Closed -$385K 2139
2017
Q2
$385K Sell
69,320
-182,740
-72% -$1.11M ﹤0.01% 1438
2017
Q1
$2.12M Buy
252,060
+168,225
+201% +$1.17M 0.01% 887
2016
Q4
$531K Buy
83,835
+2,983
+4% +$15.5K ﹤0.01% 1290
2016
Q3
$357K Sell
80,852
-23,722
-23% -$94.8K ﹤0.01% 1373
2016
Q2
$297K Buy
+104,574
New +$325K ﹤0.01% 1405
2016
Q1
Sell
-1,000
Closed -$10K 2102
2015
Q4
$10K Buy
+1,000
New +$9.94K ﹤0.01% 1792

Other funds holding BCRX